GUGGENHEIM CAPITAL LLC - CTI BIOPHARMA CORP ownership

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q1 2018$64,000
+100.0%
16,349
+38.0%
0.00%
Q4 2017$32,000
-25.6%
11,850
-11.1%
0.00%
Q3 2017$43,00013,3300.00%
Other shareholders
CTI BIOPHARMA CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 8,800,358$21,825,00010.02%
CAXTON CORP 2,239,300$5,553,0004.54%
Altium Capital Management LP 2,185,000$5,419,0001.49%
SILVERARC CAPITAL MANAGEMENT, LLC 1,483,829$3,680,0001.49%
Ghost Tree Capital, LLC 1,200,000$2,976,0001.07%
Lion Point Capital, LP 1,223,595$3,034,0000.81%
BVF INC/IL 8,929,690$22,146,0000.80%
NEA Management Company, LLC 7,140,450$17,708,0000.36%
Knott David M Jr 221,079$548,0000.19%
Lakeside Advisors, INC. 97,780$242,0000.18%
View complete list of CTI BIOPHARMA CORP shareholders